13.89
1.40 (11.21%)
| Previous Close | 12.49 |
| Open | 12.72 |
| Volume | 130,444 |
| Avg. Volume (3M) | 91,459 |
| Market Cap | 369,375,488 |
| Price / Sales | 7.43 |
| Price / Book | 3.11 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | -76.05% |
| Operating Margin (TTM) | -56.13% |
| Diluted EPS (TTM) | -0.970 |
| Quarterly Revenue Growth (YOY) | 100.30% |
| Total Debt/Equity (MRQ) | 53.19% |
| Current Ratio (MRQ) | 6.48 |
| Operating Cash Flow (TTM) | -26.21 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | Carlsmed, Inc. | Bullish | - |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | 0.50 |
|
Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient’s unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| % Held by Insiders | 4.06% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Kornitzer Capital Management Inc /Ks | 30 Sep 2025 | 55,000 |
| Burkehill Global Management, Lp | 30 Sep 2025 | 50,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 24.00 (BTIG, 72.79%) | Buy |
| Median | 22.00 (58.39%) | |
| Low | 20.00 (Truist Securities, 43.99%) | Buy |
| Average | 22.00 (58.39%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 13.66 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 07 Nov 2025 | 24.00 (72.79%) | Buy | 13.66 |
| Truist Securities | 07 Nov 2025 | 20.00 (43.99%) | Buy | 13.66 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 19 Nov 2025 | Announcement | Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference |
| 06 Nov 2025 | Announcement | Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance |
| 23 Oct 2025 | Announcement | Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 |
| 29 Sep 2025 | Announcement | Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary |
| 22 Sep 2025 | Announcement | Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index |
| 28 Aug 2025 | Announcement | Carlsmed® Reports Second Quarter 2025 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |